SAN MATEO, CA--(Marketwired - Sep 13, 2016) - Apixio Inc., the data science company for healthcare, today announced the addition of four seasoned executives to help further accelerate company growth and market share, and successfully meet the increasing demand for its cognitive computing based solutions. The new executive team members include Meg Holland, as chief operating officer; Tom McNamara, as chief sales officer; Jeff Gill, as vice president of engineering; and Tam Pham, as solutions executive. The expansion of Apixio's leadership team comes after the close of its $19.3 million in Series D funding earlier this year.
"Apixio's rapid growth over the past year has been fueled by the success of our HCC Profiler solution. With our consistently high-performing analytics for payers and providers, we have assumed a market leadership position," said Darren Schulte, MD, CEO at Apixio. "With these proven leaders and top talent, we are now better able to transform healthcare through data."
In Holland's new role as COO, she will lead Apixio's operations team to deliver superior results to an expanded customer base with current and new solutions. She brings more than 25 years of digital health experience from past business operations roles at HealthLoop, Epocrates and Accenture's Health Service Group.
"Having worked in the healthcare industry for more than two decades, I recognized Apixio's potential to have a dramatic impact on how healthcare is consumed and delivered," said Meg Holland, COO, Apixio. "I look forward to delivering a world-class experience for our customers and scaling our operations to meet our growing business needs."
As chief sales officer, McNamara will use his experience leading sales at a number of healthcare and technology companies to lead Apixio's sales team and bring its solutions to a wider range of customers. McNamara previously served as head of sales for GNS Healthcare, Connance and Silverlink Communications. He also led sales at HPR, a pioneer in healthcare information technology, up to and through a successful initial public offering.
"The healthcare industry is transforming at a very rapid pace. Payers and providers are now really interested in how to best extract insights from their clinic and hospital charts," said McNamara, chief sales officer, Apixio. "Apixio is helping this transformation by tapping into source systems and mining notes to deliver value to customers and, ultimately, patients."
In his role as vice president of engineering at Apixio, Gill will leverage his experience from Yahoo!, Genealogy.com, Apple and Unisys, where he led and motivated large cross-functional teams. He will help lead the company's engineering team as they continue to expand Apixio's technology platform to include additional applications and solutions.
Pham joins Apixio as its solutions executive and will help guide the development of its high-performing risk adjustment products. With more than a decade of experience in risk adjustment at payers and providers such as SCAN Health Plan and Monarch HealthCare, where she led risk adjustment activities, Pham has a proven track record of creating and leading strong teams and advising on managed care operations.
These four executives will join Apixio's leadership team, which includes Darren Schulte, chief executive officer, MD; John Schneider, chief technology officer; Mark Scott, chief marketing officer; and Jeff Harmon, chief financial officer. To learn more about Apixio's executive team, visit: http://www.apixio.com/team/.
Powered by its cognitive computing platform, Apixio brings advanced data to healthcare by extracting and analyzing previously trapped unstructured medical record data, giving healthcare providers unprecedented access to groundbreaking insights.
Apixio's computing platform is built upon the insights from analyzing more than 6 million patient charts. The Apixio HCC Profiler solution uses computers to mine medical charts and Medicare-reported chronic condition data for payers and providers to more efficiently and accurately conduct risk adjustment activities for Medicare Advantage.